Follow
Mai Fujiwara
Mai Fujiwara
Brigham and Women's Hospital/Harvard Medical School
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
Bacterial lipodipeptide, Lipid 654, is a microbiome‐associated biomarker for multiple sclerosis
V Farrokhi, R Nemati, FC Nichols, X Yao, E Anstadt, M Fujiwara, J Grady, ...
Clinical & translational immunology 2 (11), e8, 2013
982013
MicroRNA-146a limits tumorigenic inflammation in colorectal cancer
LP Garo, AK Ajay, M Fujiwara, G Gabriely, R Raheja, C Kuhn, B Kenyon, ...
Nature communications 12 (1), 2419, 2021
802021
Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands
RB Clark, JL Cervantes, MW Maciejewski, V Farrokhi, R Nemati, X Yao, ...
Infection and immunity 81 (9), 3479-3489, 2013
762013
Smad7 controls immunoregulatory PDL2/1-PD1 signaling in intestinal inflammation and autoimmunity
LP Garo, AK Ajay, M Fujiwara, V Beynon, C Kuhn, G Gabriely, ...
Cell reports 28 (13), 3353-3366. e5, 2019
472019
TLR tolerance as a treatment for central nervous system autoimmunity
EJ Anstadt, M Fujiwara, N Wasko, F Nichols, RB Clark
The Journal of Immunology 197 (6), 2110-2118, 2016
422016
Enhanced TLR2 responses in multiple sclerosis
M Fujiwara, EJ Anstadt, B Flynn, K Morse, C Ng, P Paczkowski, J Zhou, ...
Clinical & Experimental Immunology 193 (3), 313-326, 2018
332018
Cbl-b deficiency mediates resistance to programmed death-ligand 1/programmed death-1 regulation
M Fujiwara, EJ Anstadt, RB Clark
Frontiers in Immunology 8, 235438, 2017
322017
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
M Fujiwara, R Raheja, LP Garo, AK Ajay, R Kadowaki-Saga, ...
The Journal of clinical investigation 132 (10), 2022
202022
Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration
AK Ajay, L Zhao, S Vig, M Fujiwara, S Thakurela, S Jadhav, A Cho, ...
Cell reports 38 (10), 2022
192022
Regulation of splenic monocyte homeostasis and function by gut microbial products
P Kolypetri, S Liu, LM Cox, M Fujiwara, R Raheja, D Ghitza, A Song, ...
Iscience 24 (4), 2021
92021
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720
M Fujiwara, EJ Anstadt, KM Khanna, RB Clark
Clinical Immunology 158 (1), 103-113, 2015
92015
Treatment of experimental autoimmune encephalomyelitis with an inhibitor of phosphodiesterase-8 (PDE8)
CP Basole, RK Nguyen, K Lamothe, P Billis, M Fujiwara, AG Vang, ...
Cells 11 (4), 660, 2022
52022
Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells
G Gabriely, D Ma, S Siddiqui, L Sun, NP Skillin, H Abou-El-Hassan, ...
Iscience 24 (11), 2021
52021
Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector
RC Guayasamin, TD Reynolds, X Wei, M Fujiwara, MD Robek
Journal of Virology 88 (18), 10909-10917, 2014
42014
Cbl-b deficiency renders T cells resistant to PD-L1/PD-1 mediated suppression
M Fujiwara, EJ Anstadt, RB Clark
The Journal of Immunology 196 (1_Supplement), 55.22-55.22, 2016
32016
PD1 blockade in cancer: impact on myeloid cells
M Fujiwara, LP Garo, G Murugaiyan
Trends in Cancer 6 (6), 443-444, 2020
22020
Effects of mono-and dialkylglucosides on the characterisation and blood circulation of lipid nanoemulsions
S Takegami, A Konishi, S Okazaki, M Fujiwara, T Kitade
Journal of Microencapsulation 36 (8), 738-746, 2019
22019
Remyelination-Promoting Inflammation: Novel Role for MyD88 Signaling in Microglia/Macrophages
G Murugaiyan, M Fujiwara, LP Garo
Trends in Neurosciences 43 (7), 455-457, 2020
12020
TLR2 tolerance in EAE
EJ Anstadt, M Fujiwara, F Nichols, RB Clark
The Journal of Immunology 196 (1_Supplement), 118.12-118.12, 2016
12016
O004 Using type III interferon to improve the efficacy of vaccine and oncolytic viral vectors
TD Reynolds, RC Guayasamin, M Fujiwara, MD Robek
Cytokine 59 (3), 498, 2012
12012
The system can't perform the operation now. Try again later.
Articles 1–20